| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECH | Common Stock | Options Exercise | $227K | +3.4K | +73.82% | $66.90 | 8.01K | Aug 10, 2022 | Direct | |
| transaction | TECH | Common Stock | Sale | -$337K | -900 | -11.24% | $373.99 | 7.11K | Aug 10, 2022 | Direct | F2 |
| transaction | TECH | Common Stock | Sale | -$37.5K | -100 | -1.41% | $374.90 | 7.01K | Aug 10, 2022 | Direct | F3 |
| transaction | TECH | Common Stock | Sale | -$377K | -992 | -14.16% | $380.15 | 6.01K | Aug 10, 2022 | Direct | F4 |
| transaction | TECH | Common Stock | Sale | -$194K | -504 | -8.38% | $385.47 | 5.51K | Aug 11, 2022 | Direct | F5 |
| transaction | TECH | Common Stock | Sale | -$3.05K | -8 | -0.15% | $380.71 | 5.5K | Aug 11, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECH | Stock Option (right to buy) | Options Exercise | $0 | -3.4K | -100% | $0.00* | 0 | Aug 10, 2022 | Common Stock | 3.4K | $66.90 | Direct | |
| holding | TECH | Stock Option (right to buy) | 4K | Aug 10, 2022 | Common Stock | 4K | $87.39 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 4K | Aug 10, 2022 | Common Stock | 4K | $91.78 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 4.26K | Aug 10, 2022 | Common Stock | 4.26K | $87.34 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 3.99K | Aug 10, 2022 | Common Stock | 3.99K | $101.19 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 3.13K | Aug 10, 2022 | Common Stock | 3.13K | $125.05 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 1.9K | Aug 10, 2022 | Common Stock | 1.9K | $179.84 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 2.01K | Aug 10, 2022 | Common Stock | 2.01K | $201.64 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 1.51K | Aug 10, 2022 | Common Stock | 1.51K | $255.69 | Direct | ||||||
| holding | TECH | Stock Option (right to buy) | 633 | Aug 10, 2022 | Common Stock | 633 | $515.24 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The option vests on the earlier of the one year anniversary of the grant date (10/28/21) or the date of Bio-Techne's 2022 annual meeting of shareholders. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 373.8600 to 374.3300, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 374.8950 to 374.9000, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 380.0000 to 380.4400, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 385.2900 to 385.8900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |